(S)-Laudanosine

CAS: 2688-77-9

Ref. 3D-FL24858

Información del producto

• Nombre: (S)-Laudanosine
• Sinónimos: (1S)-1-[(3,4-Dimethoxyphenyl)methyl]-1,2,3,4-tetrahydro-6,7-dimethoxy-2-methyl-isoquinoline, (1S)-1-(3,4-dimethoxybenzyl)-6,7-dimethoxy-2-methyl-1,2,3,4-tetrahydroisoquinoline, (1S)-1-[(3,4-Dimethoxyphenyl)methyl]-1,2,3,4-tetrahydro-6,7-dimethoxy-2-methylisoquinoline, (S)-(+)-Laudanosine, 1-(3,4-Dimethoxybenzyl)-6,7-Dimethoxy-2-Methyl-1,2,3,4-Tetrahydroisoquinoline, <span class="text-smallcaps">L</span>-(+)-Laudanosine, DL-6,7-dimethoxy-1-((3,4-dimethoxyphenyl)methyl)-2-methylisoquinoline, DL-laudanosine, Isoquinoline, 1-[(3,4-dimethoxyphenyl)methyl]-1,2,3,4-tetrahydro-6,7-dimethoxy-2-methyl-, (1S)-, Isoquinoline, 1-[(3,4-dimethoxyphenyl)methyl]-1,2,3,4-tetrahydro-6,7-dimethoxy-2-methyl-, (S)-, NSC 35045, O-Methylcodamine
• CAS: 2688-77-9

Descripción

Laudanosine is a gamma-aminobutyric acid (GABA) analog that is metabolized by the liver to form laudanosine. Laudanosine has been shown to be a competitive antagonist of benzodiazepine binding sites, including those of atracurium, mivacurium chloride, and diazepam. Laudanosine has also been shown to inhibit cyclic nucleotide phosphodiesterases in vitro, with clinical relevance for its use as an anti-epileptic drug.

• Marca: Biosynth

Propiedades químicas

• Peso molecular: 357.44 g/mol
• Fórmula: C₂₁H₂₇NO₄
• Pureza: Min. 95%